The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

The FDA has approved Gilead Sciences’ lenacapavir, a twice-yearly injectable medication to prevent HIV, making it the first drug approved for adults and adolescents who are at risk. The FDA’s approval ...